Activin and Inhibin

(R,R)-GSK321 is a wild-type isocitrate dehydrogenase 1 ( WT IDH1 ) inhibitor with an IC 50 value of 120 nM. (R,R)-GSK321 as a mutant R132H IDH1 inhibitor, is an isomer of GSK321 with some wild-type cross reactivityIn Vitro(R,R)-GSK321 (0.1~3 μM: 5

(Rac)-AZD 6482 ((Rac)-KIN-193) is the racemate of AZD 6482. AZD 6482 is a potent and selective p110β inhibitor with an IC 50 of 0.69 nM.Form:Solid.

(Rac)-AZD 6482 ((Rac)-KIN-193) is the racemate of AZD 6482. AZD 6482 is a potent and selective p110β inhibitor with an IC 50 of 0.69 nM.Form:Solid.

(Rac)-AZD 6482 ((Rac)-KIN-193) is the racemate of AZD 6482. AZD 6482 is a potent and selective p110β inhibitor with an IC 50 of 0.69 nM.Form:Solid.

(Rac)-AZD 6482 ((Rac)-KIN-193) is the racemate of AZD 6482. AZD 6482 is a potent and selective p110β inhibitor with an IC 50 of 0.69 nM.Form:Solid.

(Rac)-AZD 6482 ((Rac)-KIN-193) is the racemate of AZD 6482. AZD 6482 is a potent and selective p110β inhibitor with an IC 50 of 0.69 nM.

(Rac)-BAY1238097 is a BET inhibitor, with an IC 50 of 1.02 μM for BRD4 . Used in cancer researchForm:SolidIC50&amp: Target:IC50: 1.02 μM (BRD4).

(Rac)-BAY1238097 is a BET inhibitor, with an IC 50 of 1.02 μM for BRD4 . Used in cancer researchForm:SolidIC50&amp: Target:IC50: 1.02 μM (BRD4).

(Rac)-BAY1238097 is a BET inhibitor, with an IC 50 of 1.02 μM for BRD4 . Used in cancer researchForm:SolidIC50&amp: Target:IC50: 1.02 μM (BRD4).

(Rac)-BAY1238097 is a BET inhibitor, with an IC 50 of 1.02 μM for BRD4 . Used in cancer researchForm:SolidIC50&amp: Target:IC50: 1.02 μM (BRD4).

(Rac)-BAY1238097 is a BET inhibitor, with an IC 50 of 1.02 μM for BRD4 . Used in cancer researchIC50&amp: Target:IC50: 1.02 μM (BRD4).

(Rac)-BMS-816336 (Compound 6n) is a racemate of BMS-816336. (Rac)-BMS-816336 is a potent inhibitor of human and mouse 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) enzyme with IC 50 s of 10 nM and 68 nM, respectively. (Rac)-BMS-816336 has good